Jenburkt Pharmaceuticals Limited (BOM:524731)
India
· Delayed Price · Currency is INR 998.30
-2.00 (-0.20%)
At close: Mar 9, 2026
Jenburkt Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 4,406 | 4,465 | 3,043 | 2,939 | 2,601 | 1,828 | Upgrade
|
| Market Cap Growth | -2.99% | 46.74% | 3.52% | 13.02% | 42.23% | 25.34% | Upgrade
|
| Enterprise Value | 4,326 | 3,709 | 2,488 | 2,474 | 2,149 | 1,172 | Upgrade
|
| Last Close Price | 998.30 | 998.56 | 668.58 | 633.75 | 526.89 | 363.00 | Upgrade
|
| PE Ratio | 13.59 | 13.93 | 11.71 | 11.95 | 11.66 | 11.08 | Upgrade
|
| PS Ratio | 2.67 | 2.94 | 2.14 | 2.15 | 2.10 | 1.67 | Upgrade
|
| PB Ratio | 2.41 | 2.60 | 2.10 | 2.40 | 2.22 | 1.86 | Upgrade
|
| P/TBV Ratio | 2.41 | 2.60 | 2.11 | 2.40 | 2.22 | 1.87 | Upgrade
|
| P/FCF Ratio | - | 54.50 | 54.63 | 19.66 | 41.83 | 9.99 | Upgrade
|
| P/OCF Ratio | - | 16.00 | 37.46 | 17.24 | 28.05 | 9.40 | Upgrade
|
| EV/Sales Ratio | 2.62 | 2.44 | 1.75 | 1.81 | 1.73 | 1.07 | Upgrade
|
| EV/EBITDA Ratio | 10.79 | 9.33 | 7.67 | 8.28 | 8.04 | 6.15 | Upgrade
|
| EV/EBIT Ratio | 11.61 | 9.84 | 8.08 | 8.78 | 8.45 | 6.58 | Upgrade
|
| EV/FCF Ratio | - | 45.28 | 44.68 | 16.55 | 34.56 | 6.40 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.02 | - | 0.02 | 0.06 | 0.05 | Upgrade
|
| Debt / EBITDA Ratio | 0.04 | 0.10 | - | 0.10 | 0.25 | 0.26 | Upgrade
|
| Debt / FCF Ratio | - | 0.48 | - | 0.20 | 1.09 | 0.28 | Upgrade
|
| Net Debt / Equity Ratio | -0.04 | -0.11 | -0.51 | -0.38 | -0.34 | -0.48 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.20 | -0.48 | -2.28 | -1.56 | -1.49 | -2.46 | Upgrade
|
| Net Debt / FCF Ratio | - | -2.35 | -13.28 | -3.11 | -6.41 | -2.56 | Upgrade
|
| Asset Turnover | - | 0.84 | 0.93 | 0.96 | 0.94 | 0.97 | Upgrade
|
| Inventory Turnover | - | 3.53 | 3.71 | 3.71 | 3.67 | 3.32 | Upgrade
|
| Quick Ratio | - | 2.39 | 6.01 | 4.48 | 3.00 | 3.91 | Upgrade
|
| Current Ratio | - | 3.00 | 6.70 | 5.15 | 3.57 | 4.45 | Upgrade
|
| Return on Equity (ROE) | - | 20.25% | 19.43% | 20.52% | 20.66% | 18.49% | Upgrade
|
| Return on Assets (ROA) | - | 13.04% | 12.54% | 12.37% | 12.04% | 9.87% | Upgrade
|
| Return on Invested Capital (ROIC) | 15.47% | 24.19% | 30.98% | 27.52% | 29.42% | 33.06% | Upgrade
|
| Return on Capital Employed (ROCE) | - | 21.20% | 20.70% | 22.40% | 20.90% | 17.30% | Upgrade
|
| Earnings Yield | 7.36% | 7.18% | 8.54% | 8.37% | 8.57% | 9.03% | Upgrade
|
| FCF Yield | - | 1.84% | 1.83% | 5.08% | 2.39% | 10.01% | Upgrade
|
| Dividend Yield | 1.80% | 1.80% | 2.29% | 2.27% | 2.28% | 2.81% | Upgrade
|
| Payout Ratio | - | 21.15% | 24.32% | 22.35% | 20.99% | - | Upgrade
|
| Buyback Yield / Dilution | -0.00% | - | 3.34% | 0.52% | - | - | Upgrade
|
| Total Shareholder Return | 1.80% | 1.80% | 5.63% | 2.79% | 2.28% | 2.81% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.